Nuvectis Pharma, Inc.
Hedge Funds Holdings
Last updated:
Nuvectis Pharma, Inc.‘s stocks are currently a part of 6 hedge funds’ portfolios, which represents 1.44% of the total amount of its stocks outstanding. This makes up a total of 182.36K shares of Nuvectis Pharma, Inc.. Compared to the previous quarter, the number fell by -81.47% or -801.56K shares fewer. As for the holding position changes, 50% (3) of current hedge fund investors increased the number of shares held, 16.67% (1) of current holders sold a part of the shares held, and 16.67% (1) closed the holdings completely. 1 hedge funds are new holders of Nuvectis Pharma, Inc. stock in Q1 2023, it is 16.67% of total holders.
Hedge funds holding Nuvectis Pharma (Q1 2022 – Q1 2023)
| Q1 2022 | 7 |
|---|---|
| Q2 2022 | 10 |
| Q3 2022 | 11 |
| Q4 2022 | 11 |
| Q1 2023 | 6 |
Hedge funds changes in Nuvectis Pharma positions (Q1 2022 – Q1 2023)
| Q1 2022 | 7 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2022 | 5 | 1 | 4 | 2 | -2 |
| Q3 2022 | 2 | 7 | 0 | 1 | 1 |
| Q4 2022 | 3 | 3 | 4 | 2 | -1 |
| Q1 2023 | 1 | 3 | 1 | 1 | 0 |
Top 50 hedge fund holders of Nuvectis Pharma, Inc. (NASDAQ:NVCT)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 4.48M | 632.97K | 5.662% |
| RONIT CAPITAL LLP | 3.98M | 562.54K | 5.366% |
| BALDWIN BROTHERS LLC/MA | 943K | 133K | 0.130% |
| GEODE CAPITAL MANAGEMENT, LLC | 222K | 31.44K | 0.000% |
| VANGUARD GROUP INC | 192K | 27.06K | 0.000% |
| BLACKROCK INC. Larry Fink | 100K | 14.00K | 0.000% |
| STATE STREET CORP | 83K | 11.7K | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 29K | 4.05K | 0.001% |
| UBS GROUP AG | 2K | 220 | 0.000% |
| MORGAN STANLEY | 1K | 200 | 0.000% |
| ROYAL BANK OF CANADA | 1K | 76 | 0.000% |
| CITADEL ADVISORS LLC Ken Griffin | 0 | 0 | 0.000% |